Noelle V. Frey
Hematology
3400 Civic Center Boulevard
West Pavilion, 4th Floor
Philadelphia, PA 19104
West Pavilion, 4th Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications
Publisher Correction: Decade-long persistence of CD19 CAR T cells in B cell lymphomas.
Journal: Nature medicine
Published: August 26, 2026
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.
Journal: The New England journal of medicine
Published: June 24, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia: Results from the Real-World Outcomes Collaborative of Chimeric Antigen Receptor T in Adult Acute Lymphoblastic Leukemia.
Journal: Transplantation and cellular therapy
Published: April 21, 2026
Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.
Journal: Research square
Published: February 12, 2026
Decade-long persistence of CD19 CAR T cells in B cell lymphomas.
Journal: Nature medicine
Published: December 18, 2025
T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.
Journal: Blood
Published: November 04, 2025
Erratum to 'Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome'[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9].
Journal: Transplantation and cellular therapy
Published: October 09, 2025
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene.
Journal: Blood
Published: September 19, 2025
Last Updated: 09/26/2026